ArticleBritish journal of clinical pharmacology2012

Prediction of a potentially effective dose in humans for BAY 60-5521, a potent inhibitor of cholesteryl ester transfer protein (CETP) by allometric species scaling and combined pharmacodynamic and physiologically-based pharmacokinetic modelling.

Olaf Weber et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.